MAB8002
抗-戊型肝炎病毒抗体，aa 434-457，克隆1E6
clone 1E6, Chemicon®, from mouse
别名:
HEV
登录 查看组织和合同定价。
选择尺寸
关于此项目
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
1E6, monoclonal
Species reactivity:
human
Application:
ELISA, IF, WB
Citations:
14
biological source
mouse
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
1E6, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable, immunofluorescence: suitable, western blot: suitable
isotype
IgG2b
shipped in
wet ice
Quality Level
Immunogen
表位：aa 434-457
Application
ELISA
免疫印迹
免疫荧光
最佳稀释度必须由最终用户确定。
免疫印迹
免疫荧光
最佳稀释度必须由最终用户确定。
抗戊型肝炎病毒抗体，aa 434-457，克隆1E6检测戊型肝炎病毒水平，&已发布&验证可用于WB、ELISA&IF。
研究子类别
传染病 - 病毒
传染病 - 病毒
研究类别
传染病
传染病
Biochem/physiol Actions
ORF2.1，衣壳蛋白编码区
Physical form
形式：纯化
液体形式，溶于0.02M PB和0.25M NaCl（pH 7.6）中。含0.1%叠氮化钠。
Preparation Note
自接收之日起，可在2°-8°C下储存长达12个月。
Other Notes
浓度：关于批次特定浓度请参见检验报告。
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
除非我们的目录或产品随附的其他公司文件中另有说明，否则我们的产品预期仅用于研究用途，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Fabian Z X Lean et al.
The Journal of general virology, 103(11) (2022-11-11)
Ferrets are widely used for experimental modelling of viral infections. However, background disease in ferrets could potentially confound intended experimental interpretation. Here we report the detection of a subclinical infection of ferret hepatitis E virus (FRHEV) within a colony sub-group
Martijn D B van de Garde et al.
Journal of virology, 90(9), 4394-4401 (2016-02-19)
Genotype 3 (gt3) hepatitis E virus (HEV) infections are emerging in Western countries. Immunosuppressed patients are at risk of chronic HEV infection and progressive liver damage, but no adequate model system currently mimics this disease course. Here we explore the
Xin Zhang et al.
Antiviral research, 216, 105670-105670 (2023-07-15)
The hepatitis E virus (HEV) is a major cause of hepatitis, with an estimated 3.3 million symptomatic cases annually. There is no HEV-specific treatment besides the off-label use of ribavirin and a vaccine is only available in China and Pakistan.
Shaoli Lin et al.
Current protocols in microbiology, 48, 15L-15L (2018-03-08)
Hepatitis E virus (HEV) predominantly causes acute liver disease in humans and is transmitted via the fecal-oral route. HEV infection in pregnant women can result in grave consequences, with up to 30% fatality. The HEV strains infecting humans mainly belong
Yunlong Li et al.
Antiviral research, 184, 104967-104967 (2020-11-03)
Exposure to hepatitis E virus (HEV) bears a high risk of developing chronic infection in immunocompromised patients, including organ transplant recipients and cancer patients. We aim to identify effective anti-HEV therapies through screening and repurposing safe-in-human broad-spectrum antiviral agents. In
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持